Skip to main content
. 2017 Apr 21;8(28):45643–45655. doi: 10.18632/oncotarget.17314

Figure 2.

Figure 2

(A) Western Blot was carried out to test HEXIM1 knock down in U87M and T98G glioma cell lines. (B) WST-1 cell proliferation assay was used to test the effect of HEXIM1 on JQ1 sensitivity. (C) IC50 of JQ1 on all 3 groups.